ClinConnect ClinConnect Logo
Search / Trial NCT06312098

Perioperative Factors and Living Donor Liver Transplantation

Launched by MIN SUK CHAE · Mar 8, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how different factors before, during, and after liver transplant surgery affect the chances of survival for patients and the success of the transplanted liver. Liver transplants are often necessary for people with severe liver disease, but managing patients through the entire process can be challenging for medical teams. Understanding which clinical and laboratory factors impact recovery can help improve treatments and outcomes for patients undergoing this surgery.

To be eligible for this trial, participants need to be adults who are scheduled for elective liver transplant surgery and classified as having a low to moderate risk according to the American Society of Anesthesiologists (ASA) system. This means they should be generally healthy or have mild to moderate health issues. Unfortunately, those with more serious health problems (ASA classifications IV or V) won't be able to participate. If you or a loved one qualify and choose to join, you will be monitored closely during the surgery and recovery to gather important information that could help future patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • adults
  • elective surgery
  • American Society of Anesthesiologists (ASA) physical status classification system I, II, III
  • Exclusion Criteria:
  • American Society of Anesthesiologists (ASA) physical status classification system IV, V

About Min Suk Chae

Min Suk Chae is a dedicated clinical trial sponsor committed to advancing medical research and innovation through rigorous and ethical study designs. With a focus on enhancing patient outcomes, the organization collaborates with healthcare professionals and research institutions to conduct comprehensive clinical trials across various therapeutic areas. By prioritizing safety, efficacy, and regulatory compliance, Min Suk Chae aims to contribute valuable insights to the scientific community and improve healthcare solutions for diverse populations. Their expert team is driven by a mission to facilitate the development of novel therapies that address unmet medical needs.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported